Early results of lower dose dasatinib (50 mg daily) as...

  • Main
  • 2018 / 05
  • Early results of lower dose dasatinib (50 mg daily) as...
Cancer 2018 / 05

Early results of lower dose dasatinib (50 mg daily) as frontline therapy for newly diagnosed chronic-phase chronic myeloid leukemia

Naqvi, Kiran, Jabbour, Elias, Skinner, Jeffrey, Yilmaz, Musa, Ferrajoli, Alessandra, Bose, Prithviraj, Thompson, Philip, Alvarado, Yesid, Jain, Nitin, Takahashi, Koichi, Burger, Jan, Estrov, Zeev, Bor
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Cancer
DOI:
10.1002/cncr.31357
Date:
May, 2018
File:
PDF, 409 KB
english, 2018
Conversion to is in progress
Conversion to is failed